Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.ล. (ONCSM), ฤฐstanbul ฤฐl Saฤlฤฑk Mรผdรผrlรผฤรผ Baลakลehir รam ve Sakura ลehir Hastanesi Baลhekimliฤi ile 272.999.916 TL bedelli bir hizmet sรถzleลmesi imzaladฤฑ.
Sรถzleลme, 60 aylฤฑk Kemoterapi ฤฐlaรง Hazฤฑrlama Hizmet Alฤฑmฤฑ kapsamฤฑnda yapฤฑldฤฑ. Beล yฤฑllฤฑk sรผreyi kapsayan anlaลma รงerรงevesinde Oncosem, รam ve Sakura ลehir Hastanesi’ne kemoterapi ilaรง hazฤฑrlama hizmetleri sunacak.
| Yeni ฤฐล ฤฐliลkisi | |
| Yapฤฑlan Aรงฤฑklama Gรผncelleme mi? | Hayฤฑr (No) |
| Yapฤฑlan Aรงฤฑklama Dรผzeltme mi? | Hayฤฑr (No) |
| Konuya ฤฐliลkin Daha รnce Yapฤฑlan Aรงฤฑklamanฤฑn Tarihi | – |
| Yapฤฑlan Aรงฤฑklama Ertelenmiล Bir Aรงฤฑklama mฤฑ? | Hayฤฑr (No) |
| Bildirim ฤฐรงeriฤi | |
| Yeni ฤฐล ฤฐliลkisine Baลlanan/Baลlanacak Kiลinin Niteliฤi | Mรผลteri (Customer) |
| Mรผลterinin/Tedarikรงinin Adฤฑ Soyadฤฑ/Ticaret รnvanฤฑ | ฤฐstanbul ฤฐl Saฤlฤฑk Mรผdรผrlรผฤรผ Baลakลehir รam ve Sakura ลehir Hastanesi Baลhekimliฤi Chief Physician's Office of Baลakลehir รam and Sakura City Hospital, Istanbul Provincial Directorate of Health |
| Varsa Mรผลterinin/Tedarikรงinin Ortaklฤฑฤฤฑn Kamuya Aรงฤฑklanan Son Gelir Tablosundaki Net Satฤฑลlar/Satฤฑlan Mal Maliyeti ฤฐรงindeki Payฤฑ | – |
| Varsa Mรผลterinin/Tedarikรงinin Ortaklฤฑฤฤฑn Kamuya Aรงฤฑklanan Son Bilanรงosundaki Ticari Alacaklar/Borรงlar ฤฐรงindeki Payฤฑ | – |
| ฤฐล ฤฐliลkisinin Baลlamasฤฑnฤฑn รngรถrรผldรผฤรผ Tarih | โ |
| Varsa Sรถzleลmenin รnemli Koลullarฤฑ | – |
| Yeni ฤฐล ฤฐliลkisinin Ortaklฤฑk Faaliyetlerine Etkisi | Ciro ve karlฤฑlฤฑฤa olumlu etki Positive impact on revenue and profitability |
| Aรงฤฑklamalar | |
ลirketimiz ile ฤฐstanbul ฤฐl Saฤlฤฑk Mรผdรผrlรผฤรผ Baลakลehir รam ve Sakura ลehir Hastanesi Baลhekimliฤi arasฤฑnda, โ'60 aylฤฑk Kemoterapi ฤฐlaรง Hazฤฑrlama Hizmet Alฤฑmฤฑ'' kapsamฤฑnda toplam 272.999.916 TL bedelli sรถzleลme imzalanmฤฑลtฤฑr. Sรถz konusu sรถzleลme, ลirketimizin kemoterapi ilaรง hazฤฑrlama hizmetleri alanฤฑndaki gรผรงlรผ konumunu pekiลtirmesi, uzun vadeli ve sรผrdรผrรผlebilir iล hacmine katkฤฑ saฤlamasฤฑ ve saฤlฤฑk hizmetleri alanฤฑndaki faaliyetlerinin bรผyรผmesine รถnemli รถlรงรผde destek olmasฤฑ aรงฤฑsฤฑndan รถnem arz etmektedir. Beล yฤฑllฤฑk sรถzleลme sรผresi boyunca saฤlanacak hizmet ile ลirketimizin operasyonel kapasitesinin ve sektรถrdeki etkinliฤinin daha da artฤฑrฤฑlmasฤฑ hedeflenmektedir. Kamuoyunun bilgisine saygฤฑyla duyurulur. ฤฐลbu aรงฤฑklamamฤฑzฤฑn ฤฐngilizce รงevirisi ekte yer almakta olup, aรงฤฑklama metinlerinde herhangi bir farklฤฑlฤฑk olmasฤฑ durumunda, Tรผrkรงe aรงฤฑklama esas kabul edilecektir. Our Company has entered into a contract with the Istanbul Provincial Directorate of Health, Baลakลehir รam and Sakura City Hospital Chief Physician's Office, for the provision of "60-Month Chemotherapy Drug Preparation Services" with a total contract value of TRY 272,999,916. The aforementioned contract is significant in terms of reinforcing our Company's strong position in the field of chemotherapy drug preparation services, contributing to a long-term and sustainable business volume, and providing substantial support for the growth of our activities in the healthcare sector. Throughout the five-year contract period, the services to be provided are expected to further enhance our Company's operational capacity and strengthen its effectiveness in the sector. Respectfully announced to the public. The English translation of this disclosure is attached. In the event of any discrepancy between the Turkish and English versions of the disclosure, the Turkish version shall prevail. | |
